| Record ID | ia:billtoamendinter00unit_51 |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/billtoamendinter00unit_51/billtoamendinter00unit_51_marc.xml |
| Download MARC binary | https://www.archive.org/download/billtoamendinter00unit_51/billtoamendinter00unit_51_meta.mrc |
LEADER: 01814nam 2200301Ia 4500
001 824456233
008 130115s2000 dcu l f000 0 eng d
035 $a(OCoLC)824456233
040 $aHEC$cHEC
043 $an-us---
049 $aHECA
110 1 $aUnited States.$bCongress.$bHouse.
245 12 $aA bill to amend the Internal Revenue Code of 1986 to deny tax benefits for research conducted by pharmaceutical companies where United States consumers pay higher prices for the products of that research than consumers in certain other countries.
246 1 $iShort title:$aPrescription Price Equity Act of 2000.
246 1 $iAt head of title:$a106th Congress, 2d Session, H.R. 3665 in the House of Representatives.
246 30 $aTo amend the Internal Revenue Code of 1986 to deny tax benefits for research conducted by pharmaceutical companies where United States consumers pay higher prices for the products of that research than consumers in certain other countries.
260 $a[Washington, D.C. :$bU.S. G.P.O.,$c2000]
300 $a5 p. ;$c28 cm.
590 $aCMS copy in folder: Public Laws: Bill / House / 106th Congress / 2nd Session / 2000.
500 $aCaption title.
500 $aIntroduced Feb. 15, 2000; referred to the Committee on Ways and Means.
650 0 $aDrugs$xResearch$xLaw and legislation$zUnited States.
650 0 $aPharmaceutical industry$xResearch$xTaxation$xLaw and legislation$zUnited States.
650 0 $aInternational business enterprises$xResearch$xTaxation$xLaw and legislation$zUnited States.
650 0 $aResearch and development tax credit$xLaw and legislation$zUnited States.
650 0 $aPrescription pricing$xLaw and legislation$zUnited States.
710 1 $aUnited States.$bCongress.$bHouse.$bCommittee on Ways and Means.
913 $alac jk 01/15/2013 for cms